e-learning
resources
Milan 2017
Sunday, 10.09.2017
Towards personalised medicine in COPD: biological and clinical phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood biomarker algorithms to guide COPD assessment and risk stratification
B. Masters (Billerica, United States of America)
Source:
International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Session:
Towards personalised medicine in COPD: biological and clinical phenotypes
Session type:
Oral Presentation
Number:
505
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Masters (Billerica, United States of America). Blood biomarker algorithms to guide COPD assessment and risk stratification. 505
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014
Physio-pathologic assessment to stratify risk
Source: International Congress 2019 – PG14 Perioperative management of fragile patients undergoing major thoracic surgery
Year: 2019
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Blood biomarkers in COPD: results from the ECLIPSE (evaluation of COPD longitudinally to identify predictive surrogate endpoints) cohort
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009
Harvesting biomarkers for early risk assessment
Source: Annual Congress 2008 - New age lung carcinogenesis: clinical impact
Year: 2008
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both?
Source: Eur Respir J 2015; 46: 1551-1553
Year: 2015
COPD: implementing biomarkers to improve prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021
Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer
Source: Annual Congress 2013 –Early detection of lung cancer
Year: 2013
Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Case-finding for COPD: Developing strategies to identify patients at risk populations
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Blood biomarkers predicting disease progression in patients with IPF: data from the INMARK trial
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019
Determining the best diagnostic biomarker for sepsis and prognosis assessment
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Design and assessment of an automated prediction model for 30-day re-hospitalization after a COPD exacerbation using genetic algorithms
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Importance of admission biomarkers in prognostication of patients with SARS-Cov-2
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept